Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer: SNRNP200, SRSF3 and SRRM1 as novel therapeutic targets for prostate cancer

SEBASTIAN EMILIO VENTURA SOTOMARIA JOSE REQUENA TAPIAJUAN MANUEL JIMÉNEZ VACASMANUEL DAVID GAHETE ORTIZEMILIA Mª ALORS PÉREZRAUL MIGUEL LUQUE HUERTASANTONIO CARLOS FUENTES FAYOSJUSTO PASTOR CASTAÑO FUENTES2026-01-292026-01-29202010.1016/j.ebiom.2019.11.0082-s2.0-85077377111https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/31198Biochemistry, Genetics and Molecular Biology (all)Medicine (all)Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer: SNRNP200, SRSF3 and SRRM1 as novel therapeutic targets for prostate cancerresearch article